Literature DB >> 15146101

Stepwise posttranslational processing of progrowth hormone-releasing hormone (proGHRH) polypeptide by furin and PC1.

Samuel F Posner1, Charles A Vaslet, Michelle Jurofcik, Alisson Lee, Nabil G Seidah, Eduardo A Nillni.   

Abstract

Through a posttranslational processing mechanism, pro-growth hormone releasing hormone (proGHRH) gives rise to an amidated GHRH molecule, which in turn stimulates the synthesis and release of growth hormone. We have previously proposed a model for the biochemical processing of proGHRH [Nillni et al. (1999), Endocrinology 140, 5817-5827]. We demonstrated that the proGHRH peptide (10.5 kDa, 104 aa) is first processed to an 8.8 kDa intermediate form that is later cleaved to yield two products: the 5.2 kDa GHRH and the 3.6 kDa GHRH-RP. However, the proteolytic enzymes involved in this process are unknown. Therefore, in this study we determined which proconverting enzymes are involved in this process. We transfected different constructs in cell lines carrying different PC enzymes followed by analysis of the peptide products after metabolic labeling or Western blots. We found that in the absence of furin (LoVo cells) or CHO cells treated with BFA, only one moiety was observed, and that corresponds to the same electrophorectic mobility to the GHRH precursor. This finding strongly supports an initial role for furin in the processing of proGHRH. The results from transfections with preproGHRH alone or double or triple transfections with PC1 and PC2 in AtT-20, GH3, and GH4C1 cells indicated that PC1 is the primary enzyme involved in the generation of GHRH peptide from the 8.8 kDa intermediate form. We found that AtT-20 cells (high PC1, very low PC2) were able to generate GHRH. However, GH3 cells (high PC2, but not PC1) were able to process the 8.8 kDa peptide to GHRH only after the cotransfection with the PC1 enzyme. Transfections with preproGHRH-GFP and preproGHRH-V5 provided similar results in all the cell lines analyzed. These data support the hypothesis that proGHRH is initially cleave by furin at preproGHRH29-30, followed by a second cleavage at preproGHRH74 primarily by PC1 to generate GHRH and GHRH-RP peptides, respectively. Copyright 2004 Humana Press Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15146101     DOI: 10.1385/ENDO:23:2-3:199

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.925


  36 in total

Review 1.  The cell biology of the prohormone convertases PC1 and PC2.

Authors:  L Muller; I Lindberg
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1999

Review 2.  Sorting and storage during secretory granule biogenesis: looking backward and looking forward.

Authors:  P Arvan; D Castle
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

3.  Comparative biosynthesis, covalent post-translational modifications and efficiency of prosegment cleavage of the prohormone convertases PC1 and PC2: glycosylation, sulphation and identification of the intracellular site of prosegment cleavage of PC1 and PC2.

Authors:  S Benjannet; N Rondeau; L Paquet; A Boudreault; C Lazure; M Chrétien; N G Seidah
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

4.  PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues.

Authors:  S Benjannet; N Rondeau; R Day; M Chrétien; N G Seidah
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

5.  Pro-thyrotropin-releasing hormone processing by recombinant PC1.

Authors:  E A Nillni; T C Friedman; R B Todd; N P Birch; Y P Loh; I M Jackson
Journal:  J Neurochem       Date:  1995-12       Impact factor: 5.372

6.  Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3.

Authors:  S P Smeekens; A G Montag; G Thomas; C Albiges-Rizo; R Carroll; M Benig; L A Phillips; S Martin; S Ohagi; P Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

Review 7.  Proteolytic processing mechanisms in the biosynthesis of neuroendocrine peptides: the subtilisin-like proprotein convertases.

Authors:  Y Rouillé; S J Duguay; K Lund; M Furuta; Q Gong; G Lipkind; A A Oliva; S J Chan; D F Steiner
Journal:  Front Neuroendocrinol       Date:  1995-10       Impact factor: 8.606

Review 8.  The family of subtilisin/kexin like pro-protein and pro-hormone convertases: divergent or shared functions.

Authors:  N G Seidah; M Chrétien; R Day
Journal:  Biochimie       Date:  1994       Impact factor: 4.079

9.  Differential processing of proenkephalin by prohormone convertases 1(3) and 2 and furin.

Authors:  M B Breslin; I Lindberg; S Benjannet; J P Mathis; C Lazure; N G Seidah
Journal:  J Biol Chem       Date:  1993-12-25       Impact factor: 5.157

10.  Mechanism of the facilitation of PC2 maturation by 7B2: involvement in ProPC2 transport and activation but not folding.

Authors:  L Muller; X Zhu; I Lindberg
Journal:  J Cell Biol       Date:  1997-11-03       Impact factor: 10.539

View more
  8 in total

1.  RNAi-mediated silencing of prohormone convertase (PC) 5/6 expression leads to impairment in processing of cocaine- and amphetamine-regulated transcript (CART) precursor.

Authors:  Jeffrey Stein; Rohan Shah; Donald F Steiner; Arunangsu Dey
Journal:  Biochem J       Date:  2006-11-15       Impact factor: 3.857

Review 2.  The biology and therapeutic targeting of the proprotein convertases.

Authors:  Nabil G Seidah; Annik Prat
Journal:  Nat Rev Drug Discov       Date:  2012-05       Impact factor: 84.694

3.  Differential processing of neuropeptide proprotein in human breast adenocarcinoma.

Authors:  J H Zhang; D Zhou; J You; B S Tang; P Y Li; S S Tang
Journal:  J Endocrinol Invest       Date:  2013-04-12       Impact factor: 4.256

4.  Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome.

Authors:  Lisa C Burnett; Charles A LeDuc; Carlos R Sulsona; Daniel Paull; Richard Rausch; Sanaa Eddiry; Jayne F Martin Carli; Michael V Morabito; Alicja A Skowronski; Gabriela Hubner; Matthew Zimmer; Liheng Wang; Robert Day; Brynn Levy; Ilene Fennoy; Beatrice Dubern; Christine Poitou; Karine Clement; Merlin G Butler; Michael Rosenbaum; Jean Pierre Salles; Maithe Tauber; Daniel J Driscoll; Dieter Egli; Rudolph L Leibel
Journal:  J Clin Invest       Date:  2016-12-12       Impact factor: 14.808

5.  Proprotein convertase furin regulates osteocalcin and bone endocrine function.

Authors:  Omar Al Rifai; Jacqueline Chow; Julie Lacombe; Catherine Julien; Denis Faubert; Delia Susan-Resiga; Rachid Essalmani; John Wm Creemers; Nabil G Seidah; Mathieu Ferron
Journal:  J Clin Invest       Date:  2017-10-03       Impact factor: 14.808

6.  Genetic Regulation of Female Sexual Maturation and Longevity Through Circulating IGF1.

Authors:  Rong Yuan; Daniel M Gatti; Rebecca Krier; Ethan Malay; David Schultz; Luanne L Peters; Gary A Churchill; David E Harrison; Beverly Paigen
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-07-28       Impact factor: 6.053

7.  Genetics of the first seven proprotein convertase enzymes in health and disease.

Authors:  Hannu Turpeinen; Zsuzsanna Ortutay; Marko Pesu
Journal:  Curr Genomics       Date:  2013-11       Impact factor: 2.236

8.  A novel mutation in the mouse Pcsk1 gene showing obesity and diabetes.

Authors:  Nor I A Muhsin; Liz Bentley; Ying Bai; Michelle Goldsworthy; Roger D Cox
Journal:  Mamm Genome       Date:  2020-01-23       Impact factor: 2.957

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.